30 Day Trial


Founded in 1992, ORTHOWORLD® is the only provider of strategic intelligence in the world solely focused on the global orthopaedic market. Its singular mission is helping orthopaedic companies and individuals improve their performance.

Highly specialized product offerings such as ORTHOWORLD Membership, ORTHOFLASH®, market reports, ORTHOPRENEUR®, BONEZONE® and OMTEC® empower industry participants to respond to challenges, maximize opportunities and more aggressively expand their orthopaedic businesses. We welcome the opportunity to assist you.


  • 10:00 a.m. Medicrea received FDA 510(k) clearances for its PASS® XS posterior fixation and LigaPASS® XS band connector components, designed to address spinal deformities in small stature patients.
  • 4:45 p.m. Zimmer Biomet entered into an exclusive agreement to globally distribute Nextremity Solutions' foot and ankle deformity correction products.
  • 12:30 p.m. DePuy Synthes posted 3Q16 orthopaedic revenue of US $2,251.0MM, +3.2% vs. 3Q15. (U.S. $1,343.0MM, +2.4%; ex-U.S. $908.0MM, +4.5%)
Read More

Articles of Interest All Articles

Headcount Reductions, New Appointments at Biologics and Spine Companies

Updates from Alphatec, Amedica, Carmell and Xtant Medical as they seek to support regulatory clearance and product commercialization.